Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytosorbents (CTSO) Gains from Investment Securities (2016 - 2025)

Cytosorbents' Gains from Investment Securities history spans 14 years, with the latest figure at $812800.0 for Q4 2025.

  • Quarterly results put Gains from Investment Securities at $812800.0 for Q4 2025, down 90.66% from a year ago — trailing twelve months through Dec 2025 was $812800.0 (down 90.66% YoY), and the annual figure for FY2025 was $812800.0, down 90.66%.
  • Gains from Investment Securities for Q4 2025 was $812800.0 at Cytosorbents, down from $12.8 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $12.8 million in Q3 2025 to a low of $47832.0 in Q1 2021.
  • The 5-year median for Gains from Investment Securities is $5.8 million (2022), against an average of $5.5 million.
  • The sharpest move saw Gains from Investment Securities surged 48298.03% in 2021, then tumbled 98.25% in 2022.
  • Year by year, Gains from Investment Securities stood at $138037.0 in 2021, then soared by 5822.97% to $8.2 million in 2022, then increased by 29.02% to $10.5 million in 2023, then dropped by 17.52% to $8.7 million in 2024, then crashed by 90.66% to $812800.0 in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at $812800.0, $12.8 million, and $12.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.